U.S. PHARMACOPEIA

Search USP29  
Cephapirin Benzathine
Click to View Image
(C17H17N3O6S2)2·C16H20N2 1087.30

5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[(acetyl-oxy)methyl]-8-oxo-7-[[(4-pyridinylthio)acetyl]amino]-, (6R-trans)-, compd. with N,N¢-bis(phenylmethyl)-1,2-ethanediamine (2:1).

(6R,7R)-3-(hydroxymethyl)-8-oxo-7-[2-(4-pyridylthio)acetamido]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid compound with N,N¢-dibenzylethylenediamine (2:1) [97468-37-6].
» Cephapirin Benzathine contains the equivalent of not less than 715 µg and not more than 820 µg of cephapirin (C17H17N3O6S2) per mg.
Packaging and storage— Preserve in well-closed containers.
Labeling— Label it to indicate that it is for veterinary use only.
Crystallinity 695: meets the requirements.
pH 791: between 4.0 and 7.0, in a suspension (1 in 10).
Water, Method I 921: not more than 5.0%.
Benzathine content— Using about 1 g of Cephapirin Benzathine, accurately weighed, proceed as directed in the test for Benzathine content under Penicillin G Benzathine: between 20.0% and 24.0% of benzathine (C16H20N2), calculated on the anhydrous basis, is found.
Residual solvents 467: meets the requirements.
(Official January 1, 2007)
Assay—
Solution A— Transfer about 26.2 mL of acetic acid and about 99.12 g of potassium acetate to a 4-L volumetric flask. Add 2000 mL of water, and mix to dissolve. Dilute with water to volume, and pass through a 0.45-µm nylon filter.
Solution B— Use acetonitrile.
Mobile phase— Use variable mixtures of Solution A and Solution B as directed for Chromatographic system. Make adjustments, if necessary (see System Suitability under Chromatography 621).
Extraction solution: a mixture of 400 mL of acetic acid and 600 mL of water.
Dilution buffer— Dissolve about 205 g of potassium acetate in about 800 mL of water. Adjust with acetic acid to a pH of 7.5 to 8.2. Dilute with water to 1000 mL, and pass through a 0.45-µm nylon filter.
10% Acetic acid solution— Add about 10.0 mL of acetic acid to a 100-mL volumetric flask. Mix, and dilute with water to volume.
System suitability solution— Dissolve an accurately weighed quantity of USP Cephapirin Sodium RS in 10% Acetic acid solution to prepare a solution containing a known concentration of about 2.0 mg per mL. Heat the solution at 50 for 12 to 18 hours.
Standard preparation— In duplicate, accurately weigh about 50 mg of USP Cephapirin Sodium RS, and transfer into a 25-mL volumetric flask. Add about 2.5 mL of Extraction solution and about 15.0 mL of Dilution buffer, and agitate to dissolve. Add 7.0 mL of acetonitrile, and mix well. Allow the solution to return to room temperature, and dilute with water to volume.
Assay preparation— In duplicate, weigh about 60 mg of Cephapirin Benzathine, and transfer into a 25-mL volumetric flask. Add about 2.5 mL of Extraction solution and 15.0 mL of Dilution buffer, and mix to dissolve. Add 7.0 mL of acetonitrile, and mix. Allow the flask to return to room temperature, and dilute with water to volume.
Chromatographic system (see Chromatography 621)— The liquid chromatograph is equipped with a 260-nm detector, a 3.2-mm × 15-mm guard column that contains 7-µm packing L1 and a 3.9-mm × 15-cm analytical column that contains 4-µm packing L1. The flow rate is about 2.0 mL per minute, and the columns are heated to 40. The chromatograph is programmed as follows.
Time
(minutes)
Solution A
(%)
Solution B
(%)
Elution
0–6 91.5 8.5 isocratic
6–10 91.5®80.0 8.5®20.0 linear
10–12 80.0 20.0 isocratic
12 80.0®91.5 20.0®8.5 return to initial
12–21 91.5 8.5 re-equilibration
Chromatograph the System suitability solution and the Standard preparation, and record the peak heights and valleys as directed for Procedure. Using the results from the System suitability solution, calculate the percentage of the height of the valley taken by the formula:
100(rV / ri),
in which rV is the height of the valley between cephapirin and any impurity; and ri is the impurity peak height. The percentage of the height of the valley is not more than 25% for the impurity peaks adjacent to the cephapirin peak. [note—The System suitability solution is acceptable as long as the cephapirin peak is larger than the two peaks on either side of the cephapirin peak.] The relative standard deviation for replicate injections of the Standard preparation is not more than 3.0%.
Procedure— Separately inject equal volumes (about 2 µL) of the duplicate Standard preparation and the duplicate Assay preparation into the chromatograph, record the chromatograms, and measure the areas for the major peaks. Calculate the quantity, in µg, of C17H17N3O6S2 in each mg of Cephapirin Benzathine taken by the formula:
P(WS / WU)(VU / VS)(rU / rS),
in which P is the assigned potency, in µg of cephapirin per mg, of USP Cephapirin Sodium RS; WS and WU are the quantities of USP Cephapirin Sodium RS and Cephapirin Benzathine, in mg, used to prepare the Standard preparation and the Assay preparation, respectively; VS and VU are the final volumes, in mL, of the Standard preparation and the Assay preparation, respectively; and rU and rS are the average peak areas of the cephapirin peaks obtained from the Assay preparation and the Standard preparation, respectively.
Auxiliary Information— Staff Liaison : Ian DeVeau, Ph.D., Associate Director
Expert Committee : (VET05) Veterinary Drugs 05
USP29–NF24 Page 452
Pharmacopeial Forum : Volume No. 30(2) Page 468
Phone Number : 1-301-816-8178